dermovate scalp application 0.05% w/v cutaneous solution
lexon (uk) ltd - clobetasol propionate - cutaneous solution - 0.05 percent weight/volume - clobetasol
dermovate
glaxosmithkline pharmaceuticals s.a. - clobetasol (clobetasol propionate) - cream - 0,5mg/g
dermovate
glaxosmithkline pharmaceuticals s.a. - clobetasol (clobetasol propionate) - ointment - 0,5mg/g
dermovate cream
glaxosmithkline pharmaceuticals s.a. - clobetasol (clobetasol propionate) - cream - 0,5mg/g
dermovate ointment
glaxosmithkline pharmaceuticals s.a. - clobetasol (clobetasol propionate) - ointment - 0,5mg/g
dermovate 0.05 % w/w ointment
lexon pharmaceuticals (ireland) limited - clobetasol propionate - ointment - 0.05 percent weight/weight - corticosteroids, very potent (group iv); clobetasol
dermovate scalp application 0.05% w/v cutaneous solution
lexon pharmaceuticals (ireland) limited - clobetasol propionate - cutaneous solution - 0.05 percent weight/volume - clobetasol
dermol
viatris limited - clobetasol propionate 0.0525%{relative} (5% excess included); - scalp lotion - 0.05% w/w - active: clobetasol propionate 0.0525%{relative} (5% excess included) excipient: carbomer isopropyl alcohol purified water sodium hydroxide
dermol
viatris limited - clobetasol propionate 0.525 mg/g; - topical cream - 0.05% w/w - active: clobetasol propionate 0.525 mg/g excipient: cetostearyl alcohol chlorocresol citric acid monohydrate glyceryl monostearate polyoxyethylene-glycerin monostearate propylene glycol purified water sodium citrate dihydrate white beeswax - treatment of resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas, lichen planus and discoid lupus erythematosus and other skin conditions which do not respond satisfactorily to less active steroids.
dermol
viatris limited - clobetasol propionate 0.05%{relative}; ; clobetasol propionate 0.05%{relative} - topical ointment - 0.05% w/w - active: clobetasol propionate 0.05%{relative} excipient: propylene glycol sorbitan sesquioleate white soft paraffin active: clobetasol propionate 0.05%{relative} excipient: propylene glycol sorbitan sesquioleate white soft paraffin - treatment of resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas, lichen planus and discoid lupus erythematosus and other skin conditions which do not respond satisfactorily to less active steroids.